BSE filing, NSE: FEDERALBNK. Summary written from the filing by ALFA Finder's alert engine.
Federal Bank Ltd: key numbers
- Share price
- ₹348.30
- Market cap
- ₹86,131 Cr
- Revenue (annual)
- ₹29,674 Cr
- Net profit (annual)
- ₹4,345 Cr
- P/E (TTM)
- 16.6×Sector 19.7×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 28.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Federal Bank Ltd
All →Federal Bank Employee Stock Options
Federal Bank allotted 111,880 equity shares of Rs.2 face value on exercise of employee stock options under ESOS 2010, ESOS 2017 and ESIS 2023. No cash consideration value is stated in the filing.
Federal Bank Price Movement Clarification
Federal Bank clarified to NSE that it is not in active acquisition talks and has no material undisclosed information. The Bank stated there is no material impact on the company from the news item.
Federal Bank Earnings Call Transcript: Key Takeaways
Federal Bank reported record profits driven by strong CASA growth and fee income despite margin pressure.
Federal Bank Results Update
Federal Bank reported a record net profit of ₹1,386.09 crore for Q2 FY27, up 45.10% YoY. Total business crossed ₹6 lakh crore with gross advances exceeding ₹3 lakh crore.
- Value
- ₹1,386 Cr
- new branches
- 12.0 branches
Federal Bank Investor Presentation: Key Takeaways
Federal Bank reported record quarterly net profit of ₹1,386 Cr for Q2 FY27, driven by 20% YoY growth in business franchise and total assets crossing ₹3 Lakh Cr.
Federal Bank Other Announcement
The Federal Bank Limited filed its security cover certificate for the quarter ended September 2026. All outstanding non-convertible debentures totaling Rs. 3,195 Crore are unsecured.
Other acquisition announcements
All →Laurus Labs Acquisition Worth ₹32.5 Cr
Laurus Labs approved acquiring 52% of SI & C Resins for Rs. 32.50 Crore. The acquisition makes SI&C a subsidiary for peptide resin manufacturing.
- Value
- ₹32.50 Cr
Laurus Labs Acquisition Worth ₹35.63 Cr
Laurus Labs approved buying 60% of Canada-based CRO Galenvs Sciences for USD 3.75 million (₹35.63 Cr). The deal adds an oligonucleotide R&D arm and North American presence.
- Value
- ₹35.63 Cr
Raghav Productivity Enhancers Acquisition
RPEL acquires 80% of RPEL TRLK Silicatech Private Limited for a nominal cash subscription. The target manufactures silica ramming mass and other refractories in India.
Container Corporation of India Acquisition Worth ₹485.9 Cr
CONCOR placed an order with Braithwaite & Co for 24 rakes of BLSS wagons. The deal, including GST, values at Rs.485.93 Crores.
- Value
- ₹485.9 Cr
- Execution
- Delivery by 20.06.2028
- BLSS wagons (fleet)
- 24.0 rakes
Embassy Developments Acquisition Worth ₹32.65 Cr
Embassy Developments signed an SPA to acquire 50% of Embassy Columbia Pacific ASL for ₹32.65 Crore. The JV will become wholly owned upon closing by December 2026.
- Value
- ₹32.65 Cr
- Execution
- Within the current quarter ending on December 31, 2026
MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers